Telehealth in opioid use disorder treatment: policy considerations for expanding access to care-Reference-Cited by-同舟云学术

Telehealth in opioid use disorder treatment: policy considerations for expanding access to care

Published:2023-11-20 Issue:0 Volume:0 Page:
ISSN:2702-3648
Container-title:Journal of Osteopathic Medicine
language:en
Short-container-title:

Author:

Niyibizi Auguste¹,Haveric Arman²,Irio Giselle³

Affiliation:

1. St. Lukes’s University Hospital , Bethlehem , PA , USA

2. Temple Medical School , Philadelphia , PA , USA

3. Mountainview Regional Medical Center , Las Cruces , NM , USA

Abstract

Abstract The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 was intended to address the online diversion of controlled substances. However, it inadvertently limited access to care for patients seeking medications for opioid use disorder (MOUD). During the COVID-19 pandemic, temporary flexibility in telemedicine prescriptions for MOUD were implemented. Now, with the conclusion of the public health emergency, policymakers need to develop strategies to maintain some of the lifted restrictions in order to maintain increased access to care for patients with opioid use disorder (OUD). One potential solution to address these issues is the implementation of a hybrid model combining outpatient clinics and telemedicine. This model offers the opportunity to maintain the benefits of telemedicine while ensuring comprehensive and safe care for OUD patients.

Publisher

Walter de Gruyter GmbH

Subject

Complementary and alternative medicine,Complementary and Manual Therapy

Link

https://www.degruyter.com/document/doi/10.1515/jom-2023-0215/pdf

Reference10 articles.

1. Mahmoud, H, Naal, H, Whaibeh, E, Smith, A. Telehealth-based delivery of medication-assisted treatment for opioid use disorder: a critical review of recent developments. Curr Psychiatr Rep 2022;24:375–86. https://doi.org/10.1007/s11920-022-01346-z.

2. Mattick, RP, Breen, C, Kimber, J, Davoli, M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;2:CD002207. https://doi.org/10.1002/14651858.cd002207.pub4.

3. Chan, B, Bougatsos, C, Priest, KC, McCarty, D, Grusing, S, Chou, R. Opioid treatment programs, telemedicine and COVID-19: a scoping review. Subst Abuse 2021;43:539–46. https://doi.org/10.1080/08897077.2021.1967836.

4. Weintraub, E, Greenblatt, AD, Chang, J, Himelhoch, S, Welsh, C. Expanding access to buprenorphine treatment in rural areas with the use of telemedicine. Am J Addict 2018;27:612–17. https://doi.org/10.1111/ajad.12805.

5. Dooling, BCE, Stanley, L. Extending pandemic flexibilities for opioid use disorder treatment: authorities and methods. Minn L Rev Headnotes 2021;106:74.